Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Acalabrutinib vs Rituximab Plus Idelalisib or Bendamustine in Relapsed/Refractory Chronic Lymphocytic Leukemia: ASCEND Results at similar to 4 Years of Follow-up
- Authors
- Welslau, Manfred; Jurczak, Wojciech; Pluta, Andrzej; Wach, Malgorzata; Lysak, Daniel; Simkovic, Martin; Kryachok, Irina; Illes, Arpad; De la Serna, Javier; Dolan, Sean; Campbell, Philip; Musuraca, Gerardo; Jacob, Abraham; Avery, Eric; Lee, Jae Hoon; Usenko, Ganna; Wang, Min Hui; Yu, Ting; Ghia, Paolo
- Issue Date
- Nov-2022
- Publisher
- KARGER
- Citation
- ONCOLOGY RESEARCH AND TREATMENT, v.45, no.SUPPL 3, pp.170 - 170
- Journal Title
- ONCOLOGY RESEARCH AND TREATMENT
- Volume
- 45
- Number
- SUPPL 3
- Start Page
- 170
- End Page
- 170
- ISSN
- 2296-5270
- Files in This Item
- Go to Link
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Lee, Jae Hoon
- College of Medicine (Department of Medicine)